VPAResearch

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.


Research Reports By VPAResearch

Found 1883 publications
Schistosomiasis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Schistosomiasis US$ 1,200.00 Sep, 2018 65 pages
Bacterial Vaginosis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Bacterial Vaginosis US$ 1,200.00 Sep, 2018 65 pages
Western Equine Encephalitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Western Equine Encephalitis US$ 1,200.00 Sep, 2018 65 pages
Epstein–Barr Virus (HHV-4) Infections Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Epstein–Barr Virus... US$ 1,200.00 Sep, 2018 65 pages
Cholera Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Cholera US$ 1,200.00 Sep, 2018 65 pages
Plague Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Plague US$ 1,200.00 Sep, 2018 65 pages
Influenza A virus H5N1 subtype Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Influenza A virus H5N1 subtype US$ 1,200.00 Sep, 2018 65 pages
Pyelonephritis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Pyelonephritis US$ 1,200.00 Sep, 2018 65 pages
Bacillary Dysentery (Shigellosis) Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Bacillary Dysentery... US$ 1,200.00 Sep, 2018 65 pages
West Nile Virus Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for West Nile Virus US$ 1,200.00 Sep, 2018 65 pages
Eastern Equine Encephalitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Eastern Equine Encephalitis US$ 1,200.00 Sep, 2018 65 pages
Osteomyelitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Osteomyelitis US$ 1,200.00 Sep, 2018 65 pages
Toxoplasmosis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Toxoplasmosis US$ 1,200.00 Sep, 2018 65 pages
Influenza A Virus H3N2 Subtype Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Influenza A Virus H3N2 Subtype US$ 1,200.00 Sep, 2018 65 pages
Poliomyelitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Poliomyelitis US$ 1,200.00 Sep, 2018 65 pages
African Trypanosomiasis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for African Trypanosomiasis US$ 1,200.00 Sep, 2018 65 pages
Warts Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Warts US$ 1,200.00 Sep, 2018 65 pages
Cryptococcosis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Cryptococcosis US$ 1,200.00 Sep, 2018 65 pages
Marburgvirus Infections Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Marburgvirus Infections US$ 1,200.00 Sep, 2018 65 pages
Tinea pedis (Athlete Foot) Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Tinea pedis (Athlete Foot) US$ 1,200.00 Sep, 2018 65 pages
Genital Herpes Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Genital Herpes US$ 1,200.00 Sep, 2018 65 pages
Meningitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Meningitis US$ 1,200.00 Sep, 2018 65 pages
Shingles Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Shingles US$ 1,200.00 Sep, 2018 65 pages
Coccidioidomycosis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Coccidioidomycosis US$ 1,200.00 Sep, 2018 65 pages
Lassa Hemorrhagic Fever Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Lassa Hemorrhagic Fever US$ 1,200.00 Sep, 2018 65 pages
Severe Acute Respiratory Syndrome (SARS) Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Severe Acute... US$ 1,200.00 Sep, 2018 65 pages
Equine Encephalitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Equine Encephalitis US$ 1,200.00 Sep, 2018 65 pages
Gonorrhea Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Gonorrhea US$ 1,200.00 Sep, 2018 65 pages
Rhinovirus Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Rhinovirus US$ 1,200.00 Sep, 2018 65 pages
Candidiasis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Candidiasis US$ 1,200.00 Sep, 2018 65 pages
Influenza A Virus H7N9 Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Influenza A Virus H7N9 US$ 1,200.00 Sep, 2018 65 pages
Amyloidosis R&D Pipeline Analysis Report, H2-2018 US$ 2,200.00 Aug, 2018 150 pages
Wegener Polyangiitis R&D Pipeline Analysis Report, H2-2018 US$ 2,200.00 Aug, 2018 50 pages
Tinnitus R&D Pipeline Analysis Report, H2-2018 US$ 2,200.00 Aug, 2018 50 pages
Seizures R&D Pipeline Analysis Report, H2-2018 US$ 2,200.00 Aug, 2018 170 pages
Reflux Esophagitis R&D Pipeline Analysis Report, H2-2018 US$ 2,200.00 Aug, 2018 60 pages
Presbyopia R&D Pipeline Analysis Report, H2-2018 US$ 2,200.00 Aug, 2018 30 pages
Peripheral Neuropathy R&D Pipeline Analysis Report, H2-2018 US$ 2,200.00 Aug, 2018 50 pages
Obstructive Sleep Apnea R&D Pipeline Analysis Report, H2-2018 US$ 2,200.00 Aug, 2018 40 pages
Mucopolysaccharidosis Type II (Hunter Syndrome ) R&D Pipeline Analysis Report, H2-2018 US$ 2,200.00 Aug, 2018 50 pages
Liver Cirrhosis R&D Pipeline Analysis Report, H2-2018 US$ 2,200.00 Aug, 2018 70 pages
Influenza B Infections R&D Pipeline Analysis Report, H2-2018 US$ 2,200.00 Aug, 2018 60 pages
Hospital Acquired Pneumonia (HAP) R&D Pipeline Analysis Report, H2-2018 US$ 2,200.00 Aug, 2018 120 pages
Grass Pollen Allergy R&D Pipeline Analysis Report, H2-2018 US$ 2,200.00 Aug, 2018 50 pages
Familial Amyloid Neuropathies R&D Pipeline Analysis Report, H2-2018 US$ 2,200.00 Aug, 2018 60 pages
Diphtheria R&D Pipeline Analysis Report, H2-2018 US$ 2,200.00 Aug, 2018 60 pages
Community Acquired Methicillin Resistant Staphylococcus aureus Infections R&D Pipeline Analysis Report, H2-2018 US$ 2,200.00 Aug, 2018 40 pages
Cat Allergy R&D Pipeline Analysis Report, H2-2018 US$ 2,200.00 Aug, 2018 20 pages
Bacterial Conjunctivitis R&D Pipeline Analysis Report, H2-2018 US$ 2,200.00 Aug, 2018 20 pages
Usher Syndrome R&D Pipeline Analysis Report, H2-2018 US$ 2,200.00 Aug, 2018 30 pages
1 2 3 4 5 ... 38
Skip to top